Nanotechnology-based ocular drug delivery systems: recent advances and future prospects

S Li, L Chen, Y Fu - Journal of Nanobiotechnology, 2023 - Springer
Ocular drug delivery has constantly challenged ophthalmologists and drug delivery
scientists due to various anatomical and physiological barriers. Static and dynamic ocular …

Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020

C Peng, L Kuang, J Zhao, AE Ross, Z Wang… - Journal of Controlled …, 2022 - Elsevier
Objective To perform a bibliometric analysis in the field of ocular drug delivery research to
characterize the current international trends and to present visual representations of the past …

Novel noninvasive approaches to the treatment of obesity: from pharmacotherapy to gene therapy

AM Angelidi, MJ Belanger, A Kokkinos… - Endocrine …, 2022 - academic.oup.com
Recent insights into the pathophysiologic underlying mechanisms of obesity have led to the
discovery of several promising drug targets and novel therapeutic strategies to address the …

Targeted delivery of nutraceuticals derived from food for the treatment of obesity and its related complications

Z Dai, Y Zhang, Y Meng, S Li, Z Suonan, Y Sun, J Ji… - Food Chemistry, 2023 - Elsevier
Nutraceuticals which are abundant in foods have attracted much attention due to their
bioactive activities of anti-obesity, anti-hyperlipidemia and anti-atherosclerosis …

Nanotechnology advances towards development of targeted-treatment for obesity

NRS Sibuyi, KL Moabelo, M Meyer, MO Onani… - Journal of …, 2019 - Springer
Obesity through its association with type 2 diabetes (T2D), cancer and cardiovascular
diseases (CVDs), poses a serious health threat, as these diseases contribute to high …

Notch signaling pathway: a new target for neuropathic pain therapy

Y Zhang, T Wang, S Wu, L Tang, J Wang… - The Journal of …, 2023 - Springer
The Notch gene, a highly evolutionarily conserved gene, was discovered approximately 110
years ago and has been found to play a crucial role in the development of multicellular …

[HTML][HTML] Potentialities of nanomaterials for the management and treatment of metabolic syndrome: A new insight

CO Adetunji, OS Michael, S Rathee, KRB Singh… - Materials today …, 2022 - Elsevier
Metabolic syndrome is a collection of abnormalities including insulin resistance,
hypertension, dyslipidemia, type 2 diabetes, obesity, inflammation, non-alcoholic fatty liver …

A novel dual-targeted rosiglitazone-loaded nanoparticle for the prevention of diet-induced obesity via the browning of white adipose tissue

R Hiradate, IA Khalil, A Matsuda, M Sasaki… - Journal of Controlled …, 2021 - Elsevier
Adipose tissue in the body is classified as white adipose tissue (WAT); a fat-accumulating
tissue, or brown adipose tissue (BAT); an energy-dissipating tissue. Transforming WAT-to …

SLC35D3 promotes white adipose tissue browning to ameliorate obesity by NOTCH signaling

H Wang, L Yu, J Wang, Y Zhang, M Xu, C Lv… - Nature …, 2023 - nature.com
White adipose tissue browning can promote lipid burning to increase energy expenditure
and improve adiposity. Here, we show that Slc35d3 expression is significantly lower in …

Tackling dyslipidemia in obesity from a nanotechnology perspective

LM Trandafir, G Dodi, O Frasinariu, AC Luca… - Nutrients, 2022 - mdpi.com
Obesity and dyslipidemia are the main features of metabolic syndrome, expressed mainly by
adipose tissue dysfunction and connected by similar pathways and pharmacotherapy …